Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 499.26 | 496.26 | 463.46 | 477.23 |
| Operating Revenue | - | 413.76 | 420.42 | 399.15 | 419.56 |
| Cost Of Revenue | - | 102.99 | 109.94 | 129.47 | 149.42 |
| Gross Profit | - | 396.28 | 386.32 | 333.99 | 327.82 |
| Operating Expense | - | 385.73 | 385.51 | 397.10 | 368.72 |
| Research And Development | - | 127.43 | 120.53 | 118.49 | 93.86 |
| Selling General And Administration | - | 258.30 | 264.98 | 278.62 | 274.86 |
| Total Expenses | - | 488.72 | 495.46 | 526.57 | 518.14 |
| Operating Income | - | 10.54 | 0.80 | -63.12 | -40.91 |
| Total Operating Income As Reported | - | -1,275.74 | -115.05 | -1,852.98 | -5,444.38 |
| EBITDA | - | -1,258.46 | -61.04 | -1,854.60 | -5,435.47 |
| Normalized EBITDA | - | 27.83 | 10.13 | -41.80 | -31.99 |
| EBIT | - | -1,269.33 | -75.56 | -1,872.40 | -5,460.99 |
| Interest Expense | - | 53.14 | 48.96 | 61.94 | 64.97 |
| Net Interest Income | - | -53.14 | -48.96 | -61.94 | -64.97 |
| Other Non Operating Income Expenses | - | 6.41 | -5.20 | 3.51 | -16.60 |
| Other Income Expense | - | -1,279.87 | -76.37 | -1,809.29 | -5,420.08 |
| Interest Expense Non Operating | - | 53.14 | 48.96 | 61.94 | 64.97 |
| Net Non Operating Interest Income Expense | - | -53.14 | -48.96 | -61.94 | -64.97 |
| Pretax Income | - | -1,322.46 | -124.52 | -1,934.35 | -5,525.95 |
| Tax Provision | - | 147.33 | -553.65 | -767.68 | -1,677.80 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -270.12 | -14.94 | -719.68 | -1,642.66 |
| Net Income Continuous Operations | - | -1,469.80 | 429.12 | -1,166.66 | -3,848.15 |
| Net Income From Continuing And Discontinued Operation | - | -1,469.80 | 429.12 | -1,166.66 | -3,848.15 |
| Net Income From Continuing Operation Net Minority Interest | - | -1,469.80 | 429.12 | -1,166.66 | -3,848.15 |
| Net Income | - | -1,469.80 | 429.12 | -1,166.66 | -3,848.15 |
| Net Income Common Stockholders | - | -1,469.80 | 429.12 | -1,166.66 | -4,229.52 |
| Net Income Including Noncontrolling Interests | - | -1,469.80 | 429.12 | -1,166.66 | -3,848.15 |
| Normalized Income | - | -453.63 | 485.34 | -73.55 | -87.33 |
| Diluted NI Availto Com Stockholders | - | -1,469.80 | 437.64 | -1,166.66 | -4,229.52 |
| Basic Average Shares | - | 113.21 | 136.71 | 192.55 | 277.66 |
| Diluted Average Shares | - | 113.21 | 165.66 | 192.55 | 277.66 |
| Reconciled Depreciation | - | 10.87 | 14.53 | 17.81 | 25.52 |
| Reconciled Cost Of Revenue | - | 102.99 | 109.94 | 129.47 | 149.42 |
| Total Unusual Items | - | -1,286.29 | -71.17 | -1,812.80 | -5,403.48 |
| Total Unusual Items Excluding Goodwill | - | -1,286.29 | -71.17 | -1,812.80 | -5,403.48 |
| Preferred Stock Dividends | - | - | - | - | 381.37 |
| Special Income Charges | - | -1,286.29 | -71.17 | -1,812.80 | 0 |
| Other Special Charges | - | - | -44.69 | 22.93 | - |
| Impairment Of Capital Assets | - | 1,286.29 | 115.85 | 1,789.86 | 0 |
| Gain On Sale Of Security | - | - | - | - | -5,403.48 |
| General And Administrative Expense | - | 111.42 | 115.31 | 140.54 | 151.91 |
| Other Gand A | - | 111.42 | 115.31 | 140.54 | 151.91 |
| Total Other Finance Cost | 29.15 | 53.14 | - | - | - |
| Selling And Marketing Expense | - | 146.88 | 149.67 | 138.08 | 122.96 |
| Average Dilution Earnings | - | 0 | 8.52 | 0 | 0 |
